# Effect of Boceprevir on HCV-specific T Cell Responses

> **NCT01403181** · — · COMPLETED · sponsor: **Azienda Ospedaliero-Universitaria di Parma** · enrollment: 30 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Boceprevir

## Key facts

- **NCT ID:** NCT01403181
- **Lead sponsor:** Azienda Ospedaliero-Universitaria di Parma
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-10
- **Final completion:** —
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01403181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01403181, "Effect of Boceprevir on HCV-specific T Cell Responses". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01403181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*